Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2017 Apr;58(4):424-426.
doi: 10.1007/s00108-017-0199-y.

[Ustekinumab for the treatment of Crohn's disease : UNITI-IM-UNITI]

[Article in German]
B Siegmund  1 , S Nitschmann  2
Affiliations
Comment

[Ustekinumab for the treatment of Crohn's disease : UNITI-IM-UNITI]

[Article in German]
B Siegmund et al. Internist (Berl). 2017 Apr.

Erratum in

No abstract available

PubMed Disclaimer

Comment on

  • Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease.
    Feagan BG, Sandborn WJ, Gasink C, Jacobstein D, Lang Y, Friedman JR, Blank MA, Johanns J, Gao LL, Miao Y, Adedokun OJ, Sands BE, Hanauer SB, Vermeire S, Targan S, Ghosh S, de Villiers WJ, Colombel JF, Tulassay Z, Seidler U, Salzberg BA, Desreumaux P, Lee SD, Loftus EV Jr, Dieleman LA, Katz S, Rutgeerts P; UNITI–IM-UNITI Study Group. Feagan BG, et al. N Engl J Med. 2016 Nov 17;375(20):1946-1960. doi: 10.1056/NEJMoa1602773. N Engl J Med. 2016. PMID: 27959607 Clinical Trial.

References

    1. N Engl J Med. 2012 Oct 18;367(16):1519-28 - PubMed
    1. Br J Dermatol. 2013 Apr;168(4):844-54 - PubMed
    1. Gut. 2014 Apr;63(4):567-77 - PubMed
    1. J Drugs Dermatol. 2014 Dec;13(12):1441-8 - PubMed

LinkOut - more resources